Home > Insider Trading > Bausch Health Companies Inc. > Profile

Bausch Health Companies Inc. (BHC)

Market is closed

Sector: Pharmaceutical Preparations

Insider Roster

Thomas Appio, Chief Executive Officer, 2026-02-11
Seana Carson, Evp, General Counsel, 2026-02-11
John Paulson, Director, 2026-01-02

Thomas Appio, Chief Executive Officer, 2026-02-11
Seana Carson, Evp, General Counsel, 2026-02-11
John Paulson, Director, 2026-01-02
Sandra Leung, Director, 2026-01-02
B Amy Wechsler, Director, 2026-01-02
Paulson & Co. Inc., 2025-11-28
D. Frank Lee, Director, 2025-08-22
Michael Goettler, Director, 2025-07-29
J. Aimee Lenar, Evp, Us Pharma, 2025-07-18
Hyosig Steven Lee, Svp, Controller & Cao, 2025-07-15
Brett Icahn, Director, 2025-07-02
A Christian Garcia, Director, 2025-05-20
B Sarah Kavanagh, Director, 2025-05-20
D Steven Miller, Director, 2025-05-20
Richard Mulligan, Director, 2025-05-20
N Robert Power, Director, 2025-05-20
S John Barresi, Svp, Controller & Cao, 2025-03-03
Jean-Jacques Charhon, Evp, Cfo, 2025-02-28
C Russel Robertson, Director, 2024-04-01
George Tom Vadaketh, Evp, Chief Financial Officer, 2023-09-06
Sr. W. Thomas Ross, Director, 2023-05-19
U Richard Schutter De, Director, 2023-04-04
N Argeris Karabelas, Director, 2022-06-28
C Joseph Papa, Director, 2022-05-13
Robert Spurr, President, U.s. Businesses, 2022-05-13
Christina Ackermann, Evp and General Counsel, 2022-03-11
F Joseph Gordon, Pres&Co-Head Bausch&Lomb/Int'l, 2022-03-10
Frederick Munsch, Svp, Controller and Cao, 2022-03-07
Sam Eldessouky, Evp & Chief Financial Officer, 2022-03-07
C. Andrew Eschenbach Von, Director, 2021-08-09
Valueact Holdings, L.p., Director, Other, 2021-05-03
Valueact Capital Management, L.p., Director, Other, 2021-05-03
Valueact Capital Management, Llc, Director, Other, 2021-05-03
Va Partners I, Llc, Director, Other, 2021-05-03
Valueact Holdings Gp, Llc, Director, Other, 2021-05-03
Valueact Capital Master Fund, L.p., Director, Other, 2021-05-03
Robert David Hale, Director, Other, 2021-05-03
Valueact Holdings Ii, L.p., Director, Other, 2021-05-03
Paul Herendeen, Evp and Cfo, 2021-03-11
D. William Humphries, President, Ortho-Dermatologics, 2020-12-08
Valueact Co-Invest Master Fund, L.p., Director, Other, 2020-06-10
C. Mark Mckenna, President, Salix, 2019-08-21
N Fredric Eshelman, Director, 2018-05-03
A William Ackman, Other, 2017-05-03
Pershing Square Capital Management, L.p., Other, 2017-05-03
Ps Management Gp, Llc, Other, 2017-05-03
Stephen Fraidin, Other, 2017-05-03
Alexander Robert Ingram, Director, 2017-04-04
Clem Anne Whitaker, Evp, Company Group Chairman, 2016-12-20
Ari Kellen, Evp, Company Group Chairman, 2016-12-07
L. Robert Rosiello, Evp, Corp Dev & Strategy, 2016-12-07
Mason G Morfit, Director, Other, 2016-05-11
Ann Norma Provencio, Director, 2016-05-04
Theo Kyriazi Melas, Director, 2016-05-04
Harold Ronald Farmer, Director, 2016-05-04
Bradley Howard Schiller, Chairman and Ceo, 2016-02-22
Michael J. Pearson, Chief Executive Officer, 2016-01-06
Debora Jorn, Evp, Company Group Chairman, 2015-11-24
Roswell Robert Chai-Onn, Evp, Clo, General Counsel, 2015-10-22
Pavel Mirovsky, Evp, Pres. & Gm Valeant Emena, 2015-06-24
M. Brian Stolz, Evp, Administration & Chco, 2015-06-24
W Jeffrey Ubben, Director, Other, 2015-06-12
Berghuis Katharine Stevenson, Director, 2015-05-27
Anders Lonner, Director, 2015-05-27
A Colleen Goggins, Director, 2015-05-27
Laizer Kornwasser, Evp, Company Group Chairman, 2015-04-28
Ryan Weldon, Evp, Company Group Chairman, 2014-04-30
Fred Hassan, Director, 2013-09-03
Mark Daniel Wechsler, Evo, Co. Grp. Chmn, Eye Health, 2013-08-14
Susan Hall, Global Head Of R&D, 2013-07-30
Mitchell Lloyd Segal, Director, 2013-06-18
Rajiv Silva De, President and Coo, 2013-01-08
David Jason Hanson, Evp, Company Group Chairman, 2012-12-13
E Laurence Paul, Director, 2012-06-05
Kevin Richard Masterson, Pres. & Coo, Valeant Intl. Bb, 2012-05-14
Jr Walden Philip Loberg, Evp, Interim Cfo, 2011-07-27
Robert Michael Every Van, Director, 2011-05-23
Andrew Mark Durham, Svp Human Resources, 2011-05-13
Michel Chouinard, Coo, Biovail Labs. Intl Srl, 2010-12-27
Mcdowall William Wells, Director, 2010-12-08
Jean Margaret Mulligan, Evp, Cfo, 2010-11-16
Christian Hans Fibiger, Chief Scientific Officer, 2010-10-06
Christine Mayer, Svp, Bta Pharmaceuticals, Inc., 2010-10-06
Frank Potter, Director, 2010-07-07
Randall Louis Tull, Director, 2010-07-07
David Gregory Gubitz, Svp, Corp. Devel. & Gc, 2010-07-07
Gilbert Godin, Evp & Coo, 2010-07-07
W Mark Parrish, Director, 2010-07-06
Spencer John Lanthier, Director, 2010-07-06
H. David Laidley, Director, 2010-07-06
Serge Gouin, Director, 2010-07-06
Paul John Douglas Squires, Director, 2010-07-06

Show All Insiders (92)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on February 17, 2026, 10:24am based on SEC 13F filings Last update: February 17, 2026, 10:24am

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	GoldenTree Asset Management Steven Tananbaum	34,665,731	$240,639,364	-1%	13.04%
2.	MFN Partners Farhad Nanji And Michael Demichele	6,000,000	$41,700,000		0.89%
3.	Hudson Bay Capital Management Sander Gerber	5,000,000	$34,750,000		0.11%
4.	Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell	2,723,655	$18,914,021	+1225%	0.01%
5.	Renaissance Technologies Jim Simons	1,432,191	$9,953,727	+21%	0.02%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Paulson	$6.25	2,500,000	$15,625,000.00	73,255,869	2025-11-25	Filing
Paulson	$9.00	34,721,118	$312,490,062.00	70,755,869	2025-08-14	Filing
Paulson	$7.06	86,409	$610,047.54	36,034,751	2025-08-13	Filing
Paulson	$6.88	1,156,640	$7,957,683.20	35,948,342	2025-08-12	Filing
Paulson	$6.35	2,000,000	$12,700,000.00	34,791,702	2025-08-11	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Carson Officer	$7.31	13,370	$97,734.70	499,585	2025-09-08	Filing
Lee Director	$7.66	15,912	$121,885.92	73,795	2025-08-21	Filing
Carson Officer	$8.35	440	$3,674.00	433,066	2024-12-02	Filing
Carson Officer	$6.21	13,370	$83,027.70	435,198	2024-09-06	Filing
Carson Officer	$9.80	133	$1,303.40	499,905	2024-03-04	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Vanguard Group Inc	10,679,760	$74,149,574	0%
2.	Healthcare Of Ontario Pension Plan Trust Fund	8,452,119	$58,742,227	0.1%
3.	Goldman Sachs Group Inc	5,143,641	$35,748,304	0%
4.	Ing Groep Nv	5,000,000	$34,750,000	0.21%
5.	Norges Bank	3,682,488	$25,592,393	0%

News See All

Click here to See All News